click & collect
Collect your order in-store R35 or FREE for orders over R200.
Ulsanic
Orange Flavour Effervescent 10 Tablets
Ulsanic Orange Flavour 10 Effervescent Tablets gets to work fast to provide relief from heartburn, stomach cramps and pains, indigestion, nausea and acid reflux. It also helps with peptic ulcers and to soothe an inflamed stomach lining.
In Stock
Store pick-up
Collect your order in-store R35 or FREE for orders over R200.
Standard Delivery
Door-to-door courier countrywide R80 or FREE for orders over R600.
Find in-store
See if we have this item in your closest store
R 123.00
eB: 1230
Delivered in 2 - 4 working days.
In Stock
Standard delivery
Door-to-door courier countrywide R80 or FREE for orders over R600.
More Information
Detailed information
Description:
Effervescent Tablets Orange Flavour
Detailed Description:
Gastric ulcer, duodenal ulcer, chronic gastritis and reflux oesophagitis. ULSANIC produces relief of subjective symptoms of peptic ulceration e.g. epigastric pain, hyperchlorhydria, vomiting. Maintenance treatment after successful endoscopically proven, recently healed duodenal ulcer.
Pack size:
1 Pack
Quantity in pack:
10
Marketing description:
Enjoy your appetite for life with Ulsanic
Brand:
Ulsanic
Package type:
Pack
How to use
Usage instructions:
Take one effervescent tablet three or four times a day between meals and at bedtime. Two effervescent tablets twice daily (morning and evening) has been shown to be effective for the treatment of duodenal ulcer.
Storage instructions:
24 Month shelf life. Store in a dry place at or below 25 °C. Protect from light. Keep in original packaging until required for use.
Warnings:
ULSANIC should be administered with caution in patients with renal impairment or on dialysis, due to the possibility of increased aluminium absorption. In patients with renal failure, absorption of aluminium may cause adverse effects. Aluminium accumulation and toxicity (aluminium osteodystrophy, osteomalacia, encephalopathy) have been described in patients with renal impairment. Blood levels of aluminium, phosphate, calcium, alkaline phosphatase, should be periodically measured in these patients. Caution is advised when ULSANIC is administered in patients with phosphate deficiencies as aluminium binds to phosphate in the gastrointestinal tract, inhibiting its absorption. Occasional cases of bezoar (an insoluble mass formed within the gastric lumen) have been reported in patients taking ULSANIC. Bezoars have been described in patients after administration of ULSANIC in severely ill patients in Intensive Care Units, and especially in premature infants in whom the use of ULSANIC is not recommended, and should be used with caution in patients with delayed gastric emptying or receiving concomitant enteral feeds. Since the elderly often have reduced physiological function, the dosage should be adjusted with care. The safety and efficacy of the maintenance treatment exceeding a period of 12 months have not been established. Effects on ability to drive and use machines - ULSANIC may cause dizziness and drowsiness. Patients should be cautioned about operating hazardous machinery including motor vehicles until they are reasonably certain that ULSANIC therapy does not affect them adversely.
Keep out of reach of children.